{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T02:25:20Z","timestamp":1771554320635,"version":"3.50.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T00:00:00Z","timestamp":1447891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81121003"],"award-info":[{"award-number":["81121003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Fund of China","doi-asserted-by":"crossref","award":["81170096\/81370245\/30900601"],"award-info":[{"award-number":["81170096\/81370245\/30900601"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"New Century Excellent Talents in Heilongjiang Provincial University","award":["1252-NCET-013"],"award-info":[{"award-number":["1252-NCET-013"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title\/>\n                  <jats:p>Bone marrow-derived mesenchymal stem cells (BMSCs) have emerged as a promising therapeutic strategy for cardiovascular disease. However, there is no evidence so far that BMSCs can heal pathological myocardial hypertrophy. In this study, BMSCs were indirectly cocultured with neonatal rat ventricular cardiomyocytes (NRVCs) in vitro or intramyocardially transplanted into hypertrophic hearts in vivo. The results showed that isoproterenol (ISO)-induced typical hypertrophic characteristics of cardiomyocytes were prevented by BMSCs in the coculture model in vitro and after BMSC transplantation in vivo. Furthermore, activation of the Ca2+\/calcineurin\/nuclear factor of activated T cells cytoplasmic 3 (NFATc3) hypertrophic pathway in NRVCs was abrogated in the presence of BMSCs both in vitro and in vivo. Interestingly, inhibition of vascular endothelial growth factor (VEGF) release from BMSCs, but not basic fibroblast growth factor and insulin-like growth factor 1, abolished the protective effects of BMSCs on cardiomyocyte hypertrophy. Consistently, VEGF administration attenuated ISO-induced enlargement of cellular size; the upregulation of atrial natriuretic peptide, brain natriuretic peptide, and \u03b2-myosin heavy chain expression; and the activation of Ca2+\/calcineurin\/NFATc3 hypertrophic pathways, and these pathways can be abrogated by blocking VEGFR-1 in cardiomyocytes, indicating that VEGF receptor 1 is involved in the antihypertrophic role of VEGF. We further found that the ample VEGF secretion contributing to the antihypertrophic effects of BMSCs originates from the crosstalk of BMSCs and cardiac cells but not BMSCs or cardiomyocytes alone. Interplay of mesenchymal stem cells with cardiomyocytes produced synergistic effects on VEGF release. In summary, crosstalk between mesenchymal stem cells and cardiomyocytes contributes to the inhibition of myocardial hypertrophy via inhibiting Ca2+\/calcineurin\/NFATc3 hypertrophic pathways in cardiac cells. These results provide the first evidence for the treatment of myocardial hypertrophy using BMSCs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Significance<\/jats:title>\n                  <jats:p>This study found that mesenchymal stem cells may crosstalk with cardiomyocytes, which causes a synergistic vascular endothelial growth factor (VEGF) release from both kinds of cells and then inhibits pathological cardiac remodeling following hypertrophic stimulation in cardiomyocytes in vitro and in vivo. Blockage of VEGF release from bone marrow-derived mesenchymal stem cells (BMSCs) abolishes the antihypertrophic actions of BMSCs in vitro and in vivo. On the contrary, VEGF administration attenuates hypertrophic signaling of calcineurin\/ nuclear factor of activated T cell cytoplasmic 3 signal pathways. This study provides the first evidence for the treatment of myocardial hypertrophy using BMSCs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.5966\/sctm.2015-0032","type":"journal-article","created":{"date-parts":[[2015,12,13]],"date-time":"2015-12-13T05:44:38Z","timestamp":1449985478000},"page":"1425-1435","source":"Crossref","is-referenced-by-count":38,"title":["Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy"],"prefix":"10.1093","volume":"4","author":[{"given":"Benzhi","family":"Cai","sequence":"first","affiliation":[{"name":"Department of Pharmacology, State Province Key Laboratories of Biomedicine-Pharmaceutics of China and Key Laboratories of Cardiovascular Research, Ministry of Education of China, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueying","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, State Province Key Laboratories of Biomedicine-Pharmaceutics of China and Key Laboratories of Cardiovascular Research, Ministry of Education of China, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, State Province Key Laboratories of Biomedicine-Pharmaceutics of China and Key Laboratories of Cardiovascular Research, Ministry of Education of China, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingda","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, State Province Key Laboratories of Biomedicine-Pharmaceutics of China and Key Laboratories of Cardiovascular Research, Ministry of Education of China, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, State Province Key Laboratories of Biomedicine-Pharmaceutics of China and Key Laboratories of Cardiovascular Research, Ministry of Education of China, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiuxin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, State Province Key Laboratories of Biomedicine-Pharmaceutics of China and Key Laboratories of Cardiovascular Research, Ministry of Education of China, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, State Province Key Laboratories of Biomedicine-Pharmaceutics of China and Key Laboratories of Cardiovascular Research, Ministry of Education of China, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, State Province Key Laboratories of Biomedicine-Pharmaceutics of China and Key Laboratories of Cardiovascular Research, Ministry of Education of China, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoqiu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, State Province Key Laboratories of Biomedicine-Pharmaceutics of China and Key Laboratories of Cardiovascular Research, Ministry of Education of China, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanju","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, State Province Key Laboratories of Biomedicine-Pharmaceutics of China and Key Laboratories of Cardiovascular Research, Ministry of Education of China, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoqian","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, State Province Key Laboratories of Biomedicine-Pharmaceutics of China and Key Laboratories of Cardiovascular Research, Ministry of Education of China, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenwei","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, State Province Key Laboratories of Biomedicine-Pharmaceutics of China and Key Laboratories of Cardiovascular Research, Ministry of Education of China, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, State Province Key Laboratories of Biomedicine-Pharmaceutics of China and Key Laboratories of Cardiovascular Research, Ministry of Education of China, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baofeng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, State Province Key Laboratories of Biomedicine-Pharmaceutics of China and Key Laboratories of Cardiovascular Research, Ministry of Education of China, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China"},{"name":"Cardiovascular Research Institute, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjie","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, State Province Key Laboratories of Biomedicine-Pharmaceutics of China and Key Laboratories of Cardiovascular Research, Ministry of Education of China, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China"},{"name":"Cardiovascular Research Institute, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,11,19]]},"reference":[{"key":"2021122704434098500_R1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nature10147","article-title":"Heart regeneration","volume":"473","author":"Laflamme","year":"2011","journal-title":"Nature"},{"issue":"suppl 1","key":"2021122704434098500_R2","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1038\/ncpcardio0447","article-title":"Methods of stem cell delivery in cardiac diseases","volume":"3","author":"Perin","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"2021122704434098500_R3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/hc0102.101442","article-title":"Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart","volume":"105","author":"Toma","year":"2002","journal-title":"Circulation"},{"issue":"suppl","key":"2021122704434098500_R4","first-page":"I24","article-title":"Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: Results from the Stem Cells in Myocardial Infarction (STEMMI) trial","volume":"116","author":"Ripa","year":"2007","journal-title":"Circulation"},{"key":"2021122704434098500_R5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/stem.556","article-title":"Concise review: Mesenchymal stem cell treatment of the complications of diabetes mellitus","volume":"29","author":"Volarevic","year":"2011","journal-title":"Stem Cells"},{"key":"2021122704434098500_R6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/s-2007-985154","article-title":"Bone marrow mesenchymal stem cells induce angiogenesis and attenuate the remodeling of diabetic cardiomyopathy","volume":"116","author":"Zhang","year":"2008","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2021122704434098500_R7","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/CIRCULATIONAHA.104.500447","article-title":"Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy","volume":"112","author":"Nagaya","year":"2005","journal-title":"Circulation"},{"key":"2021122704434098500_R8","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jacc.2007.11.040","article-title":"Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction","volume":"51","author":"Hahn","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2021122704434098500_R9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac hypertrophy: The good, the bad, and the ugly","volume":"65","author":"Frey","year":"2003","journal-title":"Annu Rev Physiol"},{"key":"2021122704434098500_R10","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1161\/CIRCULATIONAHA.110.942268","article-title":"Molecular pathways underlying cardiac remodeling during pathophysiological stimulation","volume":"122","author":"Kehat","year":"2010","journal-title":"Circulation"},{"key":"2021122704434098500_R11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/01926230500419421","article-title":"Cardiac hypertrophy: A risk factor for QT-prolongation and cardiac sudden death","volume":"34","author":"Kang","year":"2006","journal-title":"Toxicol Pathol"},{"key":"2021122704434098500_R12","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1161\/CIRCULATIONAHA.107.188965","article-title":"Prevention of heart failure: A scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group","volume":"117","author":"Schocken","year":"2008","journal-title":"Circulation"},{"key":"2021122704434098500_R13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.yjmcc.2009.03.002","article-title":"Bone marrow mesenchymal stem cells upregulate transient outward potassium currents in postnatal rat ventricular myocytes","volume":"47","author":"Benzhi","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"2021122704434098500_R14","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1126\/science.1095505","article-title":"Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells","volume":"304","author":"Shen","year":"2004","journal-title":"Science"},{"key":"2021122704434098500_R15","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1634\/stemcells.2006-0588","article-title":"Cardiac stem cells in brown adipose tissue express CD133 and induce bone marrow nonhematopoietic cells to differentiate into cardiomyocytes","volume":"25","author":"Yamada","year":"2007","journal-title":"Stem Cells"},{"key":"2021122704434098500_R16","doi-asserted-by":"crossref","first-page":"11397","DOI":"10.1074\/jbc.M607391200","article-title":"Acute beta-adrenergic overload produces myocyte damage through calcium leakage from the ryanodine receptor 2 but spares cardiac stem cells","volume":"282","author":"Ellison","year":"2007","journal-title":"J Biol Chem"},{"key":"2021122704434098500_R17","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/HYPERTENSIONAHA.109.139519","article-title":"Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: A novel mechanism for progressive cardiac hypertrophy","volume":"55","author":"Dong","year":"2010","journal-title":"Hypertension"},{"key":"2021122704434098500_R18","doi-asserted-by":"crossref","first-page":"12103","DOI":"10.1073\/pnas.0811371106","article-title":"miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy","volume":"106","author":"Lin","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122704434098500_R19","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1476-5381.2009.00377.x","article-title":"Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1","volume":"158","author":"Shan","year":"2009","journal-title":"Br J Pharmacol"},{"key":"2021122704434098500_R20","doi-asserted-by":"crossref","first-page":"pe31","DOI":"10.1126\/scisignal.125pe31","article-title":"Does contractile Ca2+ control calcineurin-NFAT signaling and pathological hypertrophy in cardiac myocytes?","volume":"1","author":"Houser","year":"2008","journal-title":"Sci Signal"},{"key":"2021122704434098500_R21","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.1128\/MCB.22.21.7603-7613.2002","article-title":"Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth","volume":"22","author":"Wilkins","year":"2002","journal-title":"Mol Cell Biol"},{"key":"2021122704434098500_R22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0092-8674(00)80571-1","article-title":"Generic signals and specific outcomes: Signaling through Ca2+, calcineurin, and NF-AT","volume":"96","author":"Crabtree","year":"1999","journal-title":"Cell"},{"key":"2021122704434098500_R23","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nm0405-367","article-title":"Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells","volume":"11","author":"Gnecchi","year":"2005","journal-title":"Nat Med"},{"key":"2021122704434098500_R24","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1161\/01.RES.0000225952.61196.39","article-title":"Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling","volume":"98","author":"Uemura","year":"2006","journal-title":"Circ Res"},{"key":"2021122704434098500_R25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.yjmcc.2006.10.009","article-title":"In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function","volume":"42","author":"Xu","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"2021122704434098500_R26","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/01.RES.0000073584.46059.E3","article-title":"VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses","volume":"92","author":"Rissanen","year":"2003","journal-title":"Circ Res"},{"key":"2021122704434098500_R27","doi-asserted-by":"crossref","first-page":"11474","DOI":"10.1073\/pnas.0504388102","article-title":"Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction","volume":"102","author":"Amado","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122704434098500_R28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.yjmcc.2006.10.003","article-title":"Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis","volume":"42","author":"Ohnishi","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"2021122704434098500_R29","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.105.593038","article-title":"Proarrhythmic potential of mesenchymal stem cell transplantation revealed in an in vitro coculture model","volume":"113","author":"Chang","year":"2006","journal-title":"Circulation"},{"key":"2021122704434098500_R30","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/CIRCRESAHA.110.229658","article-title":"Myocardial injection with GSK-3\u03b2-overexpressing bone marrow-derived mesenchymal stem cells attenuates cardiac dysfunction after myocardial infarction","volume":"108","author":"Cho","year":"2011","journal-title":"Circ Res"},{"key":"2021122704434098500_R31","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.yjmcc.2007.04.001","article-title":"HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia","volume":"42","author":"Dai","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"2021122704434098500_R32","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1161\/CIRCULATIONAHA.110.947531","article-title":"Notch1 in bone marrow-derived cells mediates cardiac repair after myocardial infarction","volume":"123","author":"Li","year":"2011","journal-title":"Circulation"},{"key":"2021122704434098500_R33","doi-asserted-by":"crossref","first-page":"685","DOI":"10.5966\/sctm.2012-0027","article-title":"Mesenchymal stem cell transplantation improves regional cardiac remodeling following ovine infarction","volume":"1","author":"Zhao","year":"2012","journal-title":"Stem Cells Translational Medicine"},{"key":"2021122704434098500_R34","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1440-1681.2008.05041.x","article-title":"Mesenchymal stem cells promote cardiomyocyte hypertrophy in vitro through hypoxia-induced paracrine mechanisms","volume":"36","author":"Xu","year":"2009","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2021122704434098500_R35","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.stem.2011.03.005","article-title":"A repair \u201ckit\u201d for the infarcted heart","volume":"8","author":"Mignone","year":"2011","journal-title":"Cell Stem Cell"},{"key":"2021122704434098500_R36","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/01.HYP.0000215207.54689.31","article-title":"Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload","volume":"47","author":"Izumiya","year":"2006","journal-title":"Hypertension"},{"key":"2021122704434098500_R37","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1161\/ATVBAHA.112.248674","article-title":"Vascular endothelial growth factor-induced neovascularization rescues cardiac function but not adverse remodeling at advanced ischemic heart disease","volume":"32","author":"Gordon","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2021122704434098500_R38","doi-asserted-by":"crossref","first-page":"H474","DOI":"10.1152\/ajpheart.00922.2006","article-title":"Contributory role of VEGF overexpression in endothelin-1-induced cardiomyocyte hypertrophy","volume":"293","author":"Shimojo","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2021122704434098500_R39","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jamcollsurg.2008.12.016","article-title":"Myocardial survival signaling in response to stem cell transplantation","volume":"208","author":"Li","year":"2009","journal-title":"J Am Coll Surg"},{"key":"2021122704434098500_R40","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00392-011-0330-3","article-title":"Maladaptive hypertrophy after acute myocardial infarction positive effect of bone marrow-derived stem cell therapy on regional remodeling measured by cardiac MRI","volume":"100","author":"Rolf","year":"2011","journal-title":"Clin Res Cardiol"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2015-0032","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2015-0032","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/4\/12\/1425\/41864966\/stcltm_4_12_1425.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/4\/12\/1425\/41864966\/stcltm_4_12_1425.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T02:49:32Z","timestamp":1642560572000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/4\/12\/1425-1435\/6387865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,19]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,11,19]]},"published-print":{"date-parts":[[2015,12,1]]}},"URL":"https:\/\/doi.org\/10.5966\/sctm.2015-0032","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,12,1]]},"published":{"date-parts":[[2015,11,19]]}}}